Drug Interactions Flashcards
Common CYP inducers involved in drug interactions
- Phenytoin
- Smoking
- Carbamazepine (also an auto-inducer)
- Rifampin (and rifabutin, rifapentine)
- Oxcarbazepine
- Phenobarbital
- St. John’s wort
PS CROPS
Common CYP inhibitors involved in drug interactios
- Grapefruit
- Protease inhibitors
- Azole antifungals
- Cyclosporine, cobicistat
- Macrolides (clarithromycin and erythromycin, not azithromycin)
- Amiodarone (and dronedarone)
- Non-DHP CCBs (diltiazem, and verapamil)
G <3 PACMAN
Common P-gp substrates
- Anticoagulants: apixaban, rivaroxaban, edoxaban, dabigatran
- Cardiovascular drugs: digoxin, diltiazem,verapamil, carvedilol, ranolazine
- Imunnosuppressants: tacrolimus, cyclosporinez, sirolimus
- HCV drugs: sofosbuvir
- Others: colchicine, saxagliptin, posaconazole, dolutegravir, raltegravir, atazanavir
Common P-gp inducers
- Phenytoin
- Carbamazepine
- Rifampin
- Phenobarbital
- St. John’s wort
- Dexamethasone
- Topranavir
Common P-gp inhibitors
- Cardiovascular drugs: amiodarone/dronedarone, quinidine, diltiazem, verapamil, carvedilol, conivaptan
- HIV drugs: cobicistat, ritonavir
- HCV drugs: ledipasvir
- Others: cyclosporine, flibanserin, ticagrelor
Serotonergic toxicity
- Antidepressants
- MAO inhibitors
- Opioids
- Triptans
- Natural products: St. John’s wort, L-tryptophan, SAMe
- Others: buspirone, lithium, dextromethorphan (when taken in excess as a drug of abuse)
Bleeding
- Anticoagulants
- Antiplatelets
- NSAIDs
- SSRIs, SNRIs
- Natural products: 5G’s, vitamin E, willow bark, fish oils (high dose)
Hyperkalemia
- Renin-angiotensin-aldosterone system drugs
- Potassium-sparing diuretics
- Others: salt substitutes (KCl), calcineurin inhibitors (tacrolimus and cyclosporine), SMX/TMP, canagliflozin, drospirenone-containing oral contraceptives
QT prolongation
Antiarrhythimics:
* Class 1a, 1c and III
Anti-infectives:
* Antimalarials (e.g., hydroxychloroquine)
* Azole antifungals except isavuconazonium
* Lefamulin
* Macrolides
* Quinolones
Antidepressants:
* SSRIs: highest risk with citalopram and escitalopram
* TCAs
* Others: mirtazapine, trazodone, venlafaxine
Antipsychotics:
* FGAs: thioridazine, haloperidol
* SGAs: highest risk with ziprasidone
Antiemetics:
* 5-HT3 receptor antagonists (e.g., ondansetron)
* Others: droperidol, metoclopramide, promethazine
Oncology medications
* Androgen deprivation therapy (e.g., leuprolide)
* Tyrosine kinase inhibitors (e.g., nilotinib)
* Other: oxaliplatin
Others: cilostazol, donepezil, fingolimod, hydroxyzine, loperamide, ranolazine, solifenacin, methadone, tacrolimus
CNS depression
Many drugs/drug classes
* Opioids
* Skeletal muscle relaxants
* Antiepileptic drugs
* Benzodiazepines
* Barbiturates
* Hypnotics
* Antidepressants: mirtazapine, trazodone
* Antihypertensives: propranolol, clonidine
* Cannabis-related drugs: dronabinol, nabilone
* Sedating antihistamines
* Cough syrups with an antihistamine or opioid
* Some NSAIDs
Highest risk for fatality when used in combination:
* Opioids + Benzodiazepines or other CNS depressants
Ototoxicity
- Aminoglycosides
- Cisplatin
- Loop diuretics
- Salicylates
- Vancomycin
Nephrotoxicity
- Anti-infectives: amioglycosides, amphotericin B, polymyxins, vancomycin
- Cisplatin
- Calcineurin inhibitors
- Loop diuretics
- NSAIDs
- Radiographic-contrast dye
Anticholinergic toxicity
- Antidepressants: paroxetine, TCAs
- Antipsychotics: FGAs
- Sedating antihistamines
- Centrally-acting anticholinergics
- Muscle ralaxants
- Antimuscarinics (for urinary incontinence)
- Others: atropine, belladonna, dicyclomine
Hypotension/orthostasis
PDE-5 inhibitors
+
CYP3A4 inhibitors
or
Nitrates
or
Alpha-1 blockers